22.418 articles found

Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease

PHILIPPE DELAY-GOYET, CLAIRE DELGORGE, CHRISTINE MENET, GILLES POUGHON, CHRISTINE RAVINET-TRILLOU.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET TRILLOU CHRISTINE.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

MENET CHRISTINE, DELGORGE CLAIRE, DELAY-GOYET PHILIPPE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

SUBSTITUTED 2-AMINOTETRALINES FOR THE PREVENTIVE TREATMENT OF PARKINSON'S DISEASE

SCHELLER DIETER, DRESSEN FRANK.

· 2008-04-16

Use of 4-cyclopropylmethoxy-N--(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease

MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE, DELAY-GOYET PHILIPPE, DELGORGE CLAIRE.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXSIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

Dopamine agonist therapy in early Parkinson's disease.

Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R.

Cochrane Database Syst Rev · 2008-04-16

DOI: 10.1002/14651858.cd006564.pub2PMID: 18425954

PEPTIDOMIMETIC AGENTS FROM DEXTROROTATORY AMINO ACIDS AS WELL AS PHARMACEUTICAL AGENTS THAT CONTAIN THE LATTER FOR TREATMENT OF NEURODEGENERATIVE DISEASES

WINDISCH MANFRED, HUTTER-PAIER BIRGIT, WRONSKI ROBERT.

· 2008-04-14

USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF a-SYNUCLEINOPATHIES

MCLAURIN JOANNE.

· 2008-04-11